Table 2.
Age, weeks | LZR | OZR | |
---|---|---|---|
N-tyrosine, ng/ml | 7 | 8 ± 2 | 12 ± 3 |
10 | 10 ± 2 | 22 ± 3* | |
13 | 14 ± 3 | 41 ± 5* | |
17 | 16 ± 4 | 54 ± 6* | |
20 | 20 ± 3 | 56 ± 7* | |
sVCAM, pg/ml | 7 | 8 ± 1 | 9 ± 1 |
10 | 10 ± 1 | 14 ± 2 | |
13 | 11 ± 1 | 21 ± 3* | |
17 | 12 ± 2 | 27 ± 4* | |
20 | 13 ± 3 | 29 ± 5* | |
TNF-α, pg/ml | 7 | 1.6 ± 0.4 | 4.0 ± 1.0* |
10 | 2.4 ± 0.4 | 9.9 ± 0.9* | |
13 | 2.8 ± 0.3 | 11.4 ± 1.8* | |
17 | 3.2 ± 0.4 | 13.4 ± 1.6* | |
20 | 3.4 ± 0.5 | 13.2 ± 1.7* | |
Monocyte chemoattractant protein-1, pg/ml | 7 | 29 ± 5 | 35 ± 6 |
10 | 32 ± 6 | 65 ± 8* | |
13 | 35 ± 6 | 91 ± 11* | |
17 | 38 ± 5 | 102 ± 12* | |
20 | 40 ± 6 | 114 ± 11* | |
sICAM, pg/ml | 7 | 28 ± 5 | 40 ± 6 |
10 | 29 ± 7 | 63 ± 5* | |
13 | 34 ± 6 | 64 ± 6* | |
17 | 38 ± 5 | 72 ± 7* | |
20 | 42 ± 5 | 80 ± 7* |
P < 0.05 vs. LZR.